Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Pavani

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Blood|February 18, 2011
Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivoParis Margaritis, Elise Roy, Armida Faella, et al.
Thrombosis Research|November 3, 2009
Membrane binding and anticoagulant properties of protein S natural variantsMarcello Baroni, Giulia Pavani, Diego Marescotti, et al.
Blood|August 17, 2022
The use of pluripotent stem cells to generate diagnostic tools for transfusion medicineHyun Hyung An, Alyssa L Gagne, Jean Ann Maguire, et al.
Nature Communications|July 31, 2020
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteinsGiulia Pavani, Marine Laurent, Anna Fabiano, et al.
Blood Advances|February 2, 2019
Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A ratsShannon M Zintner, Juliana C Small, Giulia Pavani, et al.
Nature Communications|August 15, 2020
Author Correction: Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteinsGiulia Pavani, Marine Laurent, Anna Fabiano, et al.
Transfusion|April 25, 2026
Rare antigen-negative red blood cells from pluripotent stem cells for precision transfusion medicineNaomi Gunawardena, Hyun Hyung An, Randall W Veliquette, et al.
Blood|December 25, 2015
Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIOscar A Marcos-Contreras, Shannon M Smith, Dwight A Bellinger, et al.
Blood Advances|February 26, 2021
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cellsGiulia Pavani, Anna Fabiano, Marine Laurent, et al.
Stem Cell Reports|May 21, 2021
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell modelSara Borst, Catriana C Nations, Joshua G Klein, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Blood|February 18, 2011
Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivoParis Margaritis, Elise Roy, Armida Faella, et al.
Thrombosis Research|November 3, 2009
Membrane binding and anticoagulant properties of protein S natural variantsMarcello Baroni, Giulia Pavani, Diego Marescotti, et al.
Blood|August 17, 2022
The use of pluripotent stem cells to generate diagnostic tools for transfusion medicineHyun Hyung An, Alyssa L Gagne, Jean Ann Maguire, et al.
Nature Communications|July 31, 2020
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteinsGiulia Pavani, Marine Laurent, Anna Fabiano, et al.
Blood Advances|February 2, 2019
Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A ratsShannon M Zintner, Juliana C Small, Giulia Pavani, et al.
Nature Communications|August 15, 2020
Author Correction: Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteinsGiulia Pavani, Marine Laurent, Anna Fabiano, et al.
Transfusion|April 25, 2026
Rare antigen-negative red blood cells from pluripotent stem cells for precision transfusion medicineNaomi Gunawardena, Hyun Hyung An, Randall W Veliquette, et al.
Blood|December 25, 2015
Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIOscar A Marcos-Contreras, Shannon M Smith, Dwight A Bellinger, et al.
Blood Advances|February 26, 2021
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cellsGiulia Pavani, Anna Fabiano, Marine Laurent, et al.
Stem Cell Reports|May 21, 2021
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell modelSara Borst, Catriana C Nations, Joshua G Klein, et al.
Pageof 4